Revvity Inc. (RVTY)
NYSE · Healthcare · Diagnostics & Research
Revvity Inc. is a Healthcare company with a market capitalization of $12.94B, a trailing P/E ratio of 55.8, and a dividend yield of 0.18%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | July 27, 2026 | $1.41 | $1.23 | +14.6% |
| Q1 2026 | May 5, 2026 | $1.06 | $1.01 | +5.0% |
| Q4 2025 | February 2, 2026 | $1.70 | $1.58 | +7.6% |
| Q3 2025 | October 27, 2025 | $1.18 | $1.14 | +3.5% |
| Q2 2025 | July 28, 2025 | $1.18 | $1.14 | +3.5% |
| Q1 2025 | April 28, 2025 | $1.01 | $0.95 | +6.3% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 7,434,687 | 6.65% | 6.8 | -2.6% |
| June 30, 2026 | 7,635,299 | 6.82% | 4.1 | -8.2% |
| June 15, 2026 | 8,317,623 | 7.43% | 6.7 | -4.9% |
| May 29, 2026 | 8,747,837 | 7.82% | 5.1 | -8.1% |
| May 15, 2026 | 9,521,763 | 8.51% | 5.6 | +8.3% |
| April 30, 2026 | 8,789,046 | 7.76% | 7.1 | +4.9% |
| April 15, 2026 | 8,375,494 | 7.40% | 11.0 | +1.6% |
| March 31, 2026 | 8,243,342 | 7.28% | 8.0 | -4.1% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Revvity Inc.'s market cap?
As of August 13, 2026, Revvity Inc. (RVTY) has a market capitalization of $12.94B.
What is Revvity Inc.'s P/E ratio?
Revvity Inc. trades at a trailing price-to-earnings (P/E) ratio of 55.8. Its forward P/E is 21.8.
Does Revvity Inc. pay a dividend?
Yes — Revvity Inc. pays a dividend yielding 0.18%, an annual payout of $0.14 per share.
What sector is RVTY in?
Revvity Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry.
What is Revvity Inc.'s short interest?
As of the July 15, 2026 FINRA settlement, 7,434,687 RVTY shares were sold short, or 6.65% of shares outstanding. Days to cover: 6.8. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Revvity Inc.'s revenue?
In its latest reported fiscal year (ending December 31, 2025), Revvity Inc. reported revenue of $2.86B and net income of $241.68M.
Ask your own questions about RVTY
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.